113 related articles for article (PubMed ID: 2229133)
1. D-19466, a new cyclobutane-platinum complex with antitumor activity.
Voegeli R; Schumacher W; Engel J; Respondek J; Hilgard P
J Cancer Res Clin Oncol; 1990; 116(5):439-42. PubMed ID: 2229133
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro effectivity of some platinum complexes.
Balázová E; Hrubisko M; Ujházy V
Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK
Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and nephrotoxicity of a novel platinum complex, [1,3-bis(diphenylphosphino)propane](trans-1-dach)platinum(I I) dinitrate.
Baek MS; Rho YS; Jung JC; Chang SG; Nomura M; Miyamoto KJ
Anticancer Res; 1997; 17(2A):955-9. PubMed ID: 9137434
[TBL] [Abstract][Full Text] [Related]
7. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
Lee K; Tashiro T; Noji M
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
[TBL] [Abstract][Full Text] [Related]
9. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of l-OHP in mice.
Mathé G; Kidani Y; Noji M; Maral R; Bourut C; Chenu E
Cancer Lett; 1985 Jun; 27(2):135-43. PubMed ID: 4039973
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and antitumor activity of water-soluble aminoalkanol platinum(II) complexes.
Khokhar AR; Xu QY; Newman RA; Siddik ZH
J Inorg Biochem; 1991 Jul; 43(1):57-63. PubMed ID: 1940901
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo.
Viale M; Zhang JG; Pastrone I; Mariggiò MA; Esposito M; Lindup WE
Anticancer Drugs; 1999 Apr; 10(4):419-28. PubMed ID: 10378678
[TBL] [Abstract][Full Text] [Related]
15. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH
J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
18. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structures and antitumor activity of the first crown ester-linked bipyridyl platinum complexes.
Yoo J; Sohn YS; Do Y
J Inorg Biochem; 1999 Mar; 73(3):187-93. PubMed ID: 10331247
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]